GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (OTCPK:TRUMY) » Definitions » Cyclically Adjusted PS Ratio

Terumo (Terumo) Cyclically Adjusted PS Ratio : 5.35 (As of Apr. 27, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Terumo Cyclically Adjusted PS Ratio?

As of today (2024-04-27), Terumo's current share price is $16.60. Terumo's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $3.10. Terumo's Cyclically Adjusted PS Ratio for today is 5.35.

The historical rank and industry rank for Terumo's Cyclically Adjusted PS Ratio or its related term are showing as below:

TRUMY' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 3.51   Med: 5.32   Max: 7.83
Current: 5.91

During the past years, Terumo's highest Cyclically Adjusted PS Ratio was 7.83. The lowest was 3.51. And the median was 5.32.

TRUMY's Cyclically Adjusted PS Ratio is ranked worse than
75.7% of 465 companies
in the Medical Devices & Instruments industry
Industry Median: 2.11 vs TRUMY: 5.91

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Terumo's adjusted revenue per share data for the three months ended in Dec. 2023 was $1.116. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $3.10 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Terumo Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Terumo's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Terumo Cyclically Adjusted PS Ratio Chart

Terumo Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.46 5.62 5.76 5.02 4.37

Terumo Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.66 4.37 5.45 4.61 5.26

Competitive Comparison of Terumo's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, Terumo's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Terumo's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Terumo's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Terumo's Cyclically Adjusted PS Ratio falls into.



Terumo Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Terumo's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=16.60/3.1
=5.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Terumo's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Terumo's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1.116/106.8000*106.8000
=1.116

Current CPI (Dec. 2023) = 106.8000.

Terumo Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.785 95.700 0.876
201406 0.741 98.000 0.808
201409 0.725 98.500 0.786
201412 0.702 97.900 0.766
201503 0.647 97.900 0.706
201506 0.642 98.400 0.697
201509 0.674 98.500 0.731
201512 0.700 98.100 0.762
201603 0.723 97.900 0.789
201606 0.760 98.100 0.827
201609 0.761 98.000 0.829
201612 0.716 98.400 0.777
201703 0.813 98.100 0.885
201706 0.831 98.500 0.901
201709 0.867 98.800 0.937
201712 0.892 99.400 0.958
201803 0.939 99.200 1.011
201806 0.857 99.200 0.923
201809 0.833 99.900 0.891
201812 0.934 99.700 1.001
201903 0.926 99.700 0.992
201906 0.933 99.800 0.998
201909 0.950 100.100 1.014
201912 0.986 100.500 1.048
202003 0.974 100.300 1.037
202006 0.806 99.900 0.862
202009 0.951 99.900 1.017
202012 1.053 99.300 1.133
202103 1.004 99.900 1.073
202106 1.031 99.500 1.107
202109 1.037 100.100 1.106
202112 1.038 100.100 1.107
202203 1.002 101.100 1.058
202206 0.973 101.800 1.021
202209 0.952 103.100 0.986
202212 1.065 104.100 1.093
202303 1.015 104.400 1.038
202306 1.022 105.200 1.038
202309 1.038 106.200 1.044
202312 1.116 106.800 1.116

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Terumo  (OTCPK:TRUMY) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Terumo Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Terumo's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Terumo (Terumo) Business Description

Traded in Other Exchanges
Address
2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.

Terumo (Terumo) Headlines

From GuruFocus

Matthews Japan Fund Picks Up 5 Stocks in 2nd Quarter

By Yamil Berard Yamil Berard 08-08-2018